Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
30,07 USD | +2,59 % | +2,28 % | +3,90 % |
Resumen de negocios
Número de empleados: 652
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Treatment of Central Nervous System Diseases
100,0
%
| 667 | 100,0 % | 608 | 100,0 % | -8,95 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 667 | 100,0 % | 608 | 100,0 % | -8,95 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jack Khattar
FOU | Founder | 62 | 30/03/05 |
Timothy Dec
DFI | Director of Finance/CFO | 66 | 23/08/21 |
Frank Mottola
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/01/05 |
Jonathan Rubin
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/02/20 |
Chief Tech/Sci/R&D Officer | 66 | 30/03/05 | |
Compliance Officer | 61 | 01/01/12 | |
Taylor Raiford
SAM | Sales & Marketing | - | 01/01/15 |
Todd Horich
SAM | Sales & Marketing | - | 31/05/18 |
Corporate Officer/Principal | - | 01/07/15 | |
Tami Martin
LAW | General Counsel | 68 | 01/01/08 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Georges Gemayel
BRD | Director/Board Member | 64 | 23/03/15 |
Charles Newhall
CHM | Chairman | 79 | 30/03/05 |
John Siebert
BRD | Director/Board Member | 84 | 01/01/11 |
Frederick Hudson
BRD | Director/Board Member | 78 | 16/11/10 |
Carrolee Barlow
BRD | Director/Board Member | 60 | 27/06/18 |
Jack Khattar
FOU | Founder | 62 | 30/03/05 |
Bethany Sensenig
BRD | Director/Board Member | 48 | 21/08/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 54 734 956 | 51 934 710 ( 94,88 %) | 0 | 94,88 % |
Información de la empresa
Supernus Pharmaceuticals, Inc.
9715 Key West Avenue
20850, Rockville
+301 838 2500
http://www.supernus.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+3,90 % | 1645,88 M | |
+5,31 % | 70,44 mil M | |
+10,97 % | 8939,13 M | |
-16,83 % | 4750,81 M | |
+43,48 % | 4497,76 M | |
+3,20 % | 3845,87 M | |
-21,36 % | 2341,22 M | |
-29,67 % | 2196,26 M | |
+8,38 % | 1963,71 M | |
-0,50 % | 1644,13 M |
- Bolsa de valores
- Acciones
- Acción SUPN
- Empresa Supernus Pharmaceuticals, Inc.